Last reviewed · How we verify
Naltrexone and Acetaminophen
At a glance
| Generic name | Naltrexone and Acetaminophen |
|---|---|
| Sponsor | Allodynic Therapeutics, Inc |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Single-Site Study of Naltrexone/Acetaminophen for the Acute Treatment of Migraine: A Phase 2 Randomized Trial (PHASE2)
- The Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen Combination (PHASE2)
- An Acute Migraine Factorial Study (PHASE2)
- Low-Dose Naltrexone and Acetaminophen Combination in the Treatment of Chronic Low Back Pain (ANODYNE-4) (PHASE2)
- Low-Dose Naltrexone and Acetaminophen Combination and Its Components in the Acute Treatment of Migraine (PHASE2)
- Low-Dose Naltrexone and Acetaminophen Combination and Sumatriptan in the Acute Treatment of Migraine With Nausea (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |